Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems

Report Scope:

The scope of the report includes an overview of the global market for nanoparticles in biotechnology, drug development and drug delivery, and analyses of global market trends, using 2019 as the base year and forecasting 2020 through 2025 with compound annual growth rate (CAGR) projections.

The report includes analysis of leading and emerging drug products for each nanoparticle type. Profiles of manufacturers of leading products and their specific products are provided. This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment. The competitive environment is examined with a special focus on how new products will alter the quality of life of patients receiving nanoparticle-associated drugs.

Market figures are based on revenues at the manufacturer level and are projected in 2019 dollar value. Inflation is not computed into the projection figures. Trends are assessed based on projected sales for existing products, for new product introductions, expanded markets for existing products, and other factors affecting the market included in this report are forecasts by product, product category and by company.

The study is arranged to offer an overview of existing nanoparticle technology and of drug markets; it is accompanied by nanoproduct, company, geography, and mechanism of action, with forecasts broken down and covered by geographic region or country.

Patent and clinical trial information is reviewed for various candidate nanodrugs. The status of approvals of drugs in each segment by the FDA and regulatory agencies in other countries is reviewed.

Figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of revenue change. Revenue figures do not account for variation in local currencies. All market share data presented is on a global basis unless specifically noted.

Regional analysis includes North America (U.S., Canada, Mexico), Europe (U.K., Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the world (South America, and the Middle East and Africa).

Report Includes:

- 43 tables
- An overview of the global nanoparticles in biotechnology, drug development and drug delivery market
- Estimation of the market size and analyses of market trends, with data from 2019, estimates for 2020 and projection of CAGR through 2025
- Highlights of the drug development, formulation, and the development of new drug delivery systems and detailed product analyses within health and wellness subsegments
- Information on nanomedicine and biomedical nanoparticle products and coverage of the next generation vaccines
- Evaluation of current market trends, market size, market forecast, and detailed analysis of drivers, challenges, and opportunities affecting market growth
- Discussion on the role of nanotechnology in COVID-19 vaccine production, components, and methods in the vaccine design for COVID-19 and challenges for vaccine disruptions
- Assessment of various approaches for the treatment of COVID-19, and detailed description of structure and penetration of corona virus
- Details of clinical trials of nanoparticle drugs and drug delivery systems
- A look at the patents, licensing, mergers and acquisitions and market share analysis of the key companies of the industry
- Company profiles of major players including Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Hofmann-La Roche Inc., Merck & Co., and Novartis AG
 


Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Market Estimate
Information Sources
Primary Research
Secondary Research
Geographic Breakdown
Analysts Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
Introduction to Nanoparticles
Liposomes
Quantum Dots
Dendrimers
Macromolecule Nanoparticles
Brief History of Nanoparticles
Nanoparticles in Biotechnology
Nanoparticles in Drug Development
Nanoparticles in Drug Delivery Systems
Nanoparticles in Diagnostic Imaging
Major Players in Nanoparticle Drug Delivery Field
Major Nanoparticle/Nanocrystal Drug Revenues
Chapter 4 Market Breakdown by Product Type
Nanoparticles in Biotechnology
Nanoparticles in Drug Development
Nanoparticles in Drug Delivery Systems
Nanoparticles in Diagnostic Imaging
Distribution of Nanobiotechnology and Nanomedicine Companies
Chapter 5 Structure of Nanoparticles
Adoption of Nanoparticles in Applied Markets
Liquid Crystals
Liquid Carriers
Liposomes
Dendrimers
Chitosan and Alginate
Nanocrystals
Quantum Dots
Application of Nanoparticles to Drugs Delivered
Chapter 6 Production of Nanoparticles
Methods of Nanoparticle Formation
Self-Assembly Production
Methods of Stabilization
Methods of Drug Introduction
Polymeric Nanoparticles
Micelles
Liposomes
Gold and Silicon Nanoparticles
Dendrimers
Methods for Loading Biological Molecules into Nanoparticles
Nanocrystal Drugs
Problems with Large-Scale Nanoparticles Production
Chapter 7 Nanoparticles in Biotechnology
Research and Development
Stem Cell Research
Cellular Repair
Paramagnetic and Superparamagnetic Nanoparticles
Biosensors and Quantum Dots
Nanoparticle Research Collaborative Programs
Chapter 8 Nanoparticles in Drug Development and Formulation
Bio Separations
Rapid Drug Analysis
Removal of Impurities and Toxins
Using Nanoparticles to Incorporate Insoluble Drugs
Gold and Silver Nanoparticles in Biomedicine
DNA Nanoparticle Development of DNA-Specific Drugs
Chapter 9 Nanoparticles in Drug Delivery Systems
Nanoparticles in Drug Delivery Applications
Designing a Nanoparticle Drug Delivery System
Nanoparticle Drug Stability
Size Homogeneity of Nanoparticle Preparations
Drug Loading of Nanoparticles
Drug Release from Nanoparticles
External Triggers for Releasing Drugs from Nanoparticles
Binding/Incorporation of Biomolecules to Nanoparticles
Nanoparticle Toxicity
Large Scale Manufacturing
Methods of Administration of Nanoparticle Drugs
Oral Administration
Injection Administration
Transdermal Patch
Implantation Administration
Inhalation Administration
Nanoparticles Suitable for Drug Delivery Systems
Lipid-Based Nanoparticles
Micelle Nanoparticles
Dendrimer Nanoparticles
Polymeric Nanoparticles
Metal-Based Nanoparticles
Biological Macromolecule Nanoparticles
Nanocrystals
Nanoparticle Drug Delivery Systems Now Available
Antibiotic Nanoparticles
Anti-Tumor and Small Molecule Delivery by Nanoparticle
Release of Anti-Cancer Drugs from Nanoparticles
Biomacromolecules Delivered by Nanoparticles
Nanoparticles Coating for Drug Delivery Systems
Removal of Nanoparticles from the body
Chapter 10 In Vitro and In Vivo Diagnostic Imaging
In Vitro Imaging
Nanoparticles in Diagnostic Imaging
Chapter 11 Biomedical Nanoparticle Products
Nanoparticle Drug Delivery Systems and Products
Major Players in Nanoparticle Drug Delivery Systems
Company Pipelines for Nanoparticle Drug Delivery
Drivers of Nanoparticle Products and Marketing
Limiters of Nanoparticle Product Development and Marketing
Chapter 12 Market Breakdown by Region
Market Overview and Discussion
North America
Europe
Asia-Pacific
Rest of the World
South America
Middle East and Africa
Chapter 13 Role of Nanotechnology in COVID-19 Vaccine Production
Introduction
Novel Coronavirus Relying on Various Approaches
Structure of COVID-19 and Penetration
Challenges for COVID-19 Vaccines
Components and Methods in the Design of Vaccines
Antigen
Adjuvant
Nanoparticle/Nanocarrier
Device
Next Generation Vaccines Enabled Through Advances in Nanotechnology
Conclusion on Nanotechnology Usage Against COVID-19
Chapter 14 Patents, Licensing, Mergers and Acquisitions
Recent Licensed, Mergers and Acquisition
Recent Licensing Activity, Mergers and Acquisition
Recent Deals
Nanoparticle Patents
Chapter 15 Company Profiles
BRISTOL-MYERS SQUIBB CO.
CAMURUS AB
CERAMISPHERE PTY LTD.
CYTIMMUNE SCIENCES
GLAXOSMITHKLINE PLC.
HOFFMANN-LA ROCHE INC.
MERCK & CO. INC.
NANOCARRIER CO. LTD.
NOVARTIS AG
 


List Of Tables


Summary Table : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery, by Product Type, Through 2025
Table 1 : Description of Nanoparticles Used in Drug Delivery and Diagnostic Imaging
Table 2 : Applications of Nanoparticles in Biotechnology
Table 3 : Applications of Nanoparticles in Drug Development
Table 4 : Applications of Nanoparticles in Drug Delivery Systems
Table 5 : Nanoparticles Used in Drug Delivery Systems
Table 6 : Nanoparticles Used for In vivo Diagnostic Imaging
Table 7 : Major Players in Nanoparticle Drug Field
Table 8 : Major Nanoparticle/Nanocrystal Drug by Product and Company
Table 9 : Global Market for Nanoparticles in Biotechnology, Through 2025
Table 10 : Global Market for Nanoparticles in Drug Development and Formulation, Through 2025
Table 11 : Global Market for Nanoparticles in Drug Delivery Systems, Through 2025
Table 12 : Global Market for Nanoparticles in Diagnostic Imaging Systems, Through 2025
Table 13 : Global Distribution of Nanobiotechnology and Nanomedicine Companies
Table 14 : Nanoparticles Structure and Properties
Table 15 : Nanoparticles Systems Approved for Drug Delivery
Table 16 : Sample of Drugs Delivered Through Liposome Nanotechnology
Table 17 : Nanoparticles in Biotechnology Applications
Table 18 : Nano Biosensor Technology Under Development
Table 19 : ETPN Strategic Research and Innovation Agenda
Table 20 : Nanoparticles in Drug Development Applications
Table 21 : Monoclonal antibody (mAb) Drugs with Potential for Use in Nanoparticles Delivery Systems
Table 22 : Solid Lipid Nanoparticles-Reformatted Drugs
Table 23 : Nanoparticles in Drug Delivery Applications
Table 24 : Standard Routes of Drug Administration
Table 25 : Nanoparticle Transdermal Patch Products
Table 26 : Type of Nanoparticles Supplied in Drug Delivery Systems
Table 27 : Mechanism for Removal of Nanoparticles from the Body
Table 28 : Nanoparticles Contrast Media Used for In Vivo Diagnostic Imaging
Table 29 : List of Marketed Products Used in Different Nanotechnology-based Techniques
Table 30 : Major Players in Nanoparticle Drug Development and Formulation Market
Table 31 : Company Pipeline for Cardiovascular Nanoparticle Drugs
Table 32 : Company Pipeline for CNS Disease Nanoparticle Drugs
Table 33 : Company Pipeline for GI Disease Nanoparticle Drugs
Table 34 : Company Pipeline for Infectious Disease Nanoparticle Drugs
Table 35 : Company Pipeline for Cancer Nanoparticle Drugs
Table 36 : Company Pipeline for Ophthalmic Nanoparticle Drugs
Table 37 : Company Pipeline for Autoimmune Disease Nanoparticle Drugs
Table 38 : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery, by Region, Through 2025
Table 39 : North American Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, Through 2025
Table 40 : European Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, Through 2025
Table 41 : Asia-Pacific Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, Through 2025
Table 42 : Global Nanotechnology, Patents, by Country, 2017-2020
Table 43 : Bristol-Myers Squibb Co.: Financials, 2017-2019
 


List Of Figures


Summary Figure : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery, by Product Type, 2019-2025
Figure 1 : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025
Figure 2 : Global Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Region, 2019-2025
Figure 3 : Global Market Share for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Region, 2019
Figure 4 : North American Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025
Figure 5 : North American Market Shares of Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, 2019
Figure 6 : European Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025
Figure 7 : European Market Shares of Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, 2019
Figure 8 : Asia-Pacific Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025
Figure 9 : Asia-Pacific Market Shares of Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, by Country, 2019
Figure 10 : South American Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025
Figure 11 : Middle Eastern and African Market for Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems, 2019-2025
 


Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems

Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems market research report available in single user pdf license with Aarkstore Enterprise at USD 5500

USD 5500 View Report

COVID-19 Outbreak-Global Metal Nanoparticles Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

The Metal Nanoparticles market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.Under COVID-19 outbreak globally, this

USD 3660 View Report

COVID-19 Outbreak-Global Metal Nanoparticles Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

The Metal Nanoparticles market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.Under COVID-19 outbreak globally, this

USD 3660 View Report

Europe Nanoparticles Instrumentation in Life Sciences Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Europe Nanoparticles Instrumentation in Life Sciences market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available